As federal lawmakers in Washington continue to slow-walk — or outright oppose — the legalisation of marijuana, the budding industry is plowing ahead making crucial inroads with another institution of prestige to help lend it legitimacy: higher education. Five universities — three public state schools and two private Catholic colleges — have partnered with cannabis education company Green […]
DEA
One doctor vs. the DEA: Inside the battle to study marijuana in America
Early in Dr. Sue Sisley’s medical career, military veterans with post-traumatic stress disorder told her that smoking marijuana prevented nightmares and helped them sleep. Sisley, a primary care physician and psychiatrist in Scottsdale, Arizona, who has treated vets for two decades, said she was initially skeptical of her patients’ claims, but their families vouched that […]
Another year passes without approval of new suppliers of marijuana for research
Forgive us if you read our stories on this topic from 2017 and 2018, but here it comes again: Another year has passed since the Drug Enforcement Administration said it was open to approving more suppliers of marijuana for scientific research, and another year has passed without an application being approved. The lag has increasingly frustrated scientists, […]
Cannabis and Hemp Industry Trembles After FDA Cracks the Whip
With the FDA “locked and loaded,” and billions of annual sales and “deal flow capital” hanging in the balance, the cannabis and hemp industries are questioning whether their products can be manufactured, sold and marketed without vending adulterated or misbranded food, drugs and cosmetics, or making false or unsubstantiated health claims. By Steve Schain Powered […]
Fifty Years: How Marijuana Became Re-Legalized In America
Part of a year-long series, longtime cannabis law reform advocate and historian Allen St. Pierre examines monthly for Cannabis Business Executive the last fifty years of cannabis prohibition and the public advocacy efforts in America to bring about the ongoing and inescapable socio-political changes underway first at the state, and soon, federal level regarding cannabis policy. […]
DEA reclassifies plant-derived marijuana medicine
According to a release issued by the National Organization for the Reform of Marijuana Laws, Epidiolex, a prescription medicine containing a standardized formulation of plant-derived cannabidiol (CBD), has been reclassified by the U.S. Drug Enforcement Administration to Schedule V — the lowest restriction classification available under federal law. Epidiolex is the first prescription drug derived from the marijuana plant. […]
Inside The Trump Administration’s Secret War On Cannabis
The White House has secretly amassed a committee of federal agencies from across the government to combat public support for marijuana and cast state legalization measures in a negative light, while attempting to portray the drug as a national threat, according to interviews with agency staff and documents obtained by BuzzFeed News. The Marijuana Policy […]
Parents Worry Feds’ Potential OK Of Medical Marijuana Could Roll Back State Programs
A British pharmaceutical company is getting closer to a decision on whether the U.S government will approve the first prescription drug derived from the marijuana plant, but parents who for years have used cannabis to treat severe forms of epilepsy in their children are feeling more cautious than celebratory. The U.S. Food and Drug Administration […]
Fifty Years: How Marijuana Became Re-Legalized In America
Part of a year-long series, longtime cannabis law reform advocate and historian Allen St. Pierre examines monthly for Cannabis Business Executive the last fifty years of cannabis prohibition and the public advocacy efforts in America to bring about the ongoing and inescapable socio-political changes underway first at the state, and soon, federal level regarding cannabis policy. […]
Feds Unlikely To Pursue Michigan Medical Marijuana, But Treasury Will
There is good news and bad news for the fledgling marijuana industry in Michigan. The good news first: The federal budget passed by Congress and signed by President Donald Trump on Friday includes language that continues the policy that the federal government shouldn’t use resources to enforce federal drug laws in states that have legalized medical […]
